Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 05/22/17
End: 11/30/22
Due: 11/30/23
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 11/30/17
Due: 11/30/18
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 05/31/19
Due: 05/31/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Mitralign Percutaneous Annuloplasty First in Man Study | NCT01852149 | Mitralign, Inc. | user2@example.com | None | 2009-08-31 | 2015-09-30 | 2016-09-30 | - | - | 2025-07-14 |
| Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) | NCT03225612 | Mitralign, Inc. | user2@example.com | None | 2017-05-22 | 2022-11-30 | 2023-11-30 | - | - | 2025-07-14 |
| Mitralign Percutaneous Annuloplasty System for Chronic Functional Mitral Valve Regurgitation | NCT01740583 | Mitralign, Inc. | user2@example.com | None | 2012-11-30 | 2017-11-30 | 2018-11-30 | - | - | 2025-07-14 |
| Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™. | NCT02574650 | Mitralign, Inc. | user2@example.com | None | 2015-11-30 | 2019-05-31 | 2020-05-31 | - | - | 2025-07-14 |